![]() |
市場調査レポート
商品コード
1439488
子宮鏡検査機器 - 世界市場の考察、競合情勢、市場予測(2030年)Hysteroscopes/Hysteroscopy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
||||||
カスタマイズ可能
適宜更新あり
|
子宮鏡検査機器 - 世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の子宮鏡検査機器の市場規模は、2023年に12億9,000万米ドル、2030年までに21億3,000万米ドルに達し、2024年~2030年の予測期間にCAGRで7.40%の成長が見込まれます。子宮鏡検査機器に対する需要の増加は主に、婦人科疾患の症例の増加と、世界中での老年女性人口が増加によるものです。さらに、低侵襲手術への選好の変化、製品分野における技術の進歩、製品承認の増加などが、市場の成長を促進すると予測される主な要因です。
子宮鏡検査機器の市場力学
子宮鏡検査機器市場は、世界中の女性における婦人科疾患の増加により、現在勢いを増しています。世界保健機関(WHO)(2022)のデータによると、子宮内膜症は、子宮の内膜に似た組織が子宮の外で成長する疾患で、世界の生殖年齢の女性と女児のおよそ10%が罹患しています。
さらに、GLOBOCAN(2020)の統計によると、2020年に世界で新たに報告された女性のがん患者数は922万7,484人で、そのうち子宮頸がんは6.5%の60万4,127人でした。
さらに、高齢化傾向にある女性の負担が増大していることも、今後数年間に子宮鏡検査機器市場を急成長させる要因の1つです。高齢女性は、性器脱、閉経後出血などのさまざまな婦人科疾患を発症しやすいからです。例えば、World Population Ageing 2020 highlightsによると、世界の65歳以上の人口は約7億2,700万人で、女性が65歳以上の世界人口の約55%を占めています。
さらに、さまざまな先進の子宮鏡検査機器の製品承認の増加も、予測期間に子宮鏡検査機器市場を急成長させると予測されています。例えば、Karl Storz SE & Co.KGは2020年7月、尿管や上部尿路などに無菌灌流液を注入する子宮鏡用送気機器「Endomat Select」のFDA認可を取得しました。
また、2020年1月にはLiNA Medical ApSが、婦人科の診断および治療中の子宮頸管や子宮腔の視覚化を目的とした子宮鏡「LiNA OperaScope」のFDA承認を取得しました。
したがって、上記のすべての要因が予測期間に世界の子宮鏡検査機器市場を急成長させると予測されます。
しかし、子宮鏡からの感染リスクや子宮鏡検査機器の厳しい規制承認プロセスが、子宮鏡検査機器市場の抑制要因になる可能性が高いです。
さらに、子宮鏡検査機器市場は、COVID-19パンデミック中に成長が鈍化しました。これは、パンデミックが世界の健康上の緊急事態を引き起こし、ソーシャルディスタンスを置くことを強制し、発生の管理に向けて病院のリソースを温存するため、不要不急の受診を停止したためです。加えて、パンデミック中の選択的外科手術の停止、感染伝播を抑制するための世界各国政府による厳格なガイドラインの実施も、子宮鏡検査機器市場を減速させました。しかし、さまざまなワクチンの発売や集団予防接種の推進が、パンデミック後の期間に子宮鏡検査市場が平常を取り戻すのに役立つ見込みです。
子宮鏡検査機器市場のセグメント分析
子宮鏡検査機器製品セグメントでは、硬性子宮鏡と軟性子宮鏡のサブカテゴリを持つ子宮鏡セグメントが今後数年間で大きな市場シェアを占めると予測されます。軟性子宮鏡は、それに関連するさまざまな利点により、硬性子宮鏡よりも好まれています。例えば、直径の小さい軟性子宮鏡は、いくつかの研究で標準的な硬性子宮鏡よりもいくつかの利点を示しています。子宮頸管や腱を拡張する必要がないため、侵襲が少ないです。そのため、これらの特徴が苦痛の少なさに関連しています。
さらに、最新の軟性子宮鏡検査機器は著しく改良されています。新しい光ファイバー、ビデオシステム、カメラ、照明がシステムの品質を向上させています。
当レポートでは、世界の子宮鏡検査機器器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Hysteroscopy Devices Market By Product Type (Hysteroscopes [Rigid Hysteroscopes And Flexible Hysteroscopes], Hand-Held Instruments [Forceps, Scissors, Dilators, Others], Hysteroscopic Fluid Management Systems, Hysteroscopic Tissue Removal Systems, Hystero-Resectoscopes, Others), By Usability (Reusable Instruments And Disposable Instruments), By Application (Diagnostic Hysteroscopy And Operative Hysteroscopy [Myomectomy, Polypectomy, Endometrial Ablation, Others]), By End-User (Hospitals, Ambulatory Surgical Centers, And Others), by geography, is anticipated to expand at a noteworthy CAGR forecast till 2030 due to the growing prevalence of gynaecological disorders and rising adoption rate of minimally invasive surgeries.
The global hysteroscopy devices market was valued at USD 1.29 billion in 2023, growing at a CAGR of 7.40% during the forecast period from 2024 to 2030, to reach USD 2.13 billion by 2030. The increase in demand for hysteroscopy devices is predominantly attributed to the rising geriatric women population across the globe coupled with growing cases of gynecological disorders. In addition, shifting preferences towards minimally invasive surgeries, technological advancements in the product arena, and rising product approvals, among others, are some of the key factors which is expected to drive the growth of the global hysteroscopy devices market.
Hysteroscopy Devices Market Dynamics:
The market for hysteroscopy devices is gaining momentum at present owing to the rise in gynecological disorders among women across the globe. As per the World Health Organization (WHO) 2022 data, Endometriosis, a disease where tissue similar to the lining of the uterus grows outside the uterus affects roughly 10% (190 million) of reproductive age women and girls globally.
Moreover, according to the GLOBOCAN 2020 statistics, a total of 9,227,484 new cancer cases were reported among females, worldwide in the year 2020, out of which 6.5% or 604,127 were suffering from cervix uteri cancer.
In addition, the escalating burden of the women population tending towards old age is also another factor that could surge the market for hysteroscopy devices in the upcoming years. This is because old women are more susceptible to developing various gynecological disorders such as genital prolapse, postmenopausal bleeding, and others. For instance, according to the World Population Ageing 2020 highlights, there were approximately 727 million population aged 65 years or over, worldwide and women accounted for about 55% of the global population aged 65 years or over.
Furthermore, rising product approval of various advanced hysteroscopy devices is also anticipated to spike the market for hysteroscopy devices during the forecasted period. For instance, in July 2020, Karl Storz SE & Co. KG received FDA clearance for its Endomat Select, a hysteroscopy insufflator to provide the infusion of the sterile irrigant solutions into the ureter and upper urinary tract, and others.
Also, in January 2020, LiNA Medical ApS received FDA approval for LiNA OperaScope, a hysteroscope intended for use in the visualization of the cervical canal and uterine cavity during diagnostic and therapeutic gynecological procedures.
Thus, all the above-mentioned factors are expected to surge the global market for hysteroscopy devices during the forecasted period.
However, the risk of infection from hysteroscopes and stringent regulatory approval process for hysteroscopy devices is likely to impede the hysteroscopy devices market.
Further, the market for hysteroscopy devices witnessed slow growth during the COVID-19 pandemic. This is because the pandemic has caused a global health emergency, enforcing social distancing and preserving hospital resources for the management of the outbreak thus suspending nonessential medical visits. In addition, halt in elective surgical procedures during the pandemic, implementation of stringent guidelines by the national governments across the globe to curb the transmission of the infection also slowed down the hysteroscopy devices market. However, the launch of various vaccines and mass vaccination drives will help in regaining normalcy to the hysteroscopy market during the post-pandemic period.
Hysteroscopy Devices Market Segment Analysis:
Hysteroscopy Devices Market By Product Type (Hysteroscopes [Rigid Hysteroscopes and Flexible Hysteroscopes], Hand-Held Instruments [Forceps, Scissors, Dilators, Others], Hysteroscopic Fluid Management Systems, Hysteroscopic Tissue Removal Systems, Hystero-Resectoscopes, Others), By Usability (Reusable Instruments and Disposable Instruments), By Application (Diagnostic Hysteroscopy and Operative Hysteroscopy [Myomectomy, Polypectomy, Endometrial Ablation, Others]), By End-User (Hospitals, Ambulatory Surgical Centers, and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the Hysteroscopy Devices product segment, the hysteroscopes segment which is further subcategorized into rigid and flexible hysteroscopes is expected to hold a significant market share in the forthcoming years. The flexible hysteroscope is preferred over rigid hysteroscope due to various advantages associated with it. For instance, flexible hysteroscopes with smaller diameters have shown some advantages over standard rigid hysteroscopes in some studies. They are less invasive because there is no requirement for the dilation of the cervix or tendons. Thus, these features are associated with less pain.
Moreover, the latest flexible hysteroscopy equipment has been significantly improved. New fiber optics, video systems, cameras, and lighting have improved the quality of the systems.
For instance, in March 2019, Hologic received a CE mark for its Omni hysteroscope, a three-in-one modular scope with visualization capabilities designed for both diagnostic and therapeutic hysteroscopy procedures. The reusable rod lens of the hysteroscope utilizes rod lenses for visualization and fibers for illumination.
Hence, all the aforementioned factors are projected to contribute to the segmental growth of the global hysteroscopy devices market in the upcoming years.
North America is expected to dominate the Overall Hysteroscopy Devices Market:
Among all the regions, North America is expected to occupy a major share in the overall Hysteroscopy Devices market during the forthcoming years. This domination is owing to the increasing concern of gynecological and reproductive health problems among the women in the region. In addition, the rise in hysteroscopy procedures in the region, the presence of well-established reimbursement policies for hysteroscopy, and the rise in awareness about women's health, among others are also expected to bolster the market for hysteroscopy devices.
For instance, in the US, according to the American Cancer Society 2022 statistics, approximately 66,750 new cases of uterine/endometrial cancer are expected to be diagnosed in the same year.
In addition, as per the Office of the Assistant Secretary for Health (OASH) 2019 data, more than 11% of American women between 15 and 44 age were suffering from endometriosis in the same year.
Furthermore, an increase in hysteroscopy procedures in the country will also contribute to the market growth of hysteroscopy devices. For instance, as per the data revealed by the Center for Menstrual Disorders 2022, in the year 2017, there were over 500,000 hysteroscopic endometrial ablations performed in the United States per year. The center has performed nearly 3500 major operative hysteroscopy procedures till January 2018.
Moreover, the presence of key manufacturers in the region such as Medtronic, Hologic, CooperSurgical, and Stryker, among others, and various product approvals belonging to hysteroscopy procedures are anticipated to spike the market for hysteroscopy devices in the region. For instance, recently on September 25, 2020, Stryker received FDA clearance for various versions of Reprocessed MyoSure Tissue Removal Devices to hysteroscopically resect and remove tissue such as submucous myomas, endometrial polyps, and retained products of conception.
Thus, all the above-stated factors are expected to propel the hysteroscopy devices market in the region.
Further, the Asia-pacific region has future potential for the hysteroscopy devices market. The increasing old-age female population is the key driving factor. For instance, according to the United Nations Population Fund 2022 statistics, the number of older people in the Asia-Pacific will triple reaching 1.3 billion by 2050 where women constitute the majority (53%) of the population aged 60 or older in the region. It is also estimated that their share will rise to 60% for ages above 80 years. Additionally, the rising burden of gynecological disorders, presence of regional as well as global leaders active in manufacturing hysteroscopy devices such as Olympus and Advin Health Care, among others in the region is likely to contribute to the market growth during the forecasted period.
Hysteroscopy Devices Market Key Players:
Some of the key market players operating in the Hysteroscopy Devices market include Medtronic, Olympus, Stryker, Hologic, Boston Scientific Corporation, KARL STORZ, Richard Wolf GmbH., Advin Health Care, Ethicon (Johnson & Johnson), MEDGYN PRODUCTS, INC., CooperSurgical Inc., Cook, Maxer Endoscopy GmbH, Meditrina, Inc., XION, EMOS Technology GmbH, LUMINELLE® (UVision360), LiNA Medical ApS, RUDOLF Medical GmbH + Co. KG, Ackermann, among others.
Recent Developmental Activities in the Hysteroscopy Devices Market:
In October 2022, Hologic launched its expanded gynecological surgical offering, Omni suite, in Europe, Africa, and the Middle East (EMEA). The expanded offering currently includes a versatile Omni 30° hysteroscope, the Omni Lok cervical seal, and the Omni 5 French seal.
In January 2022, Hologic launched Fluent® Fluid Management System for hysteroscopic procedures in Europe.
In May 2020, Olympus signed an exclusive agreement with UVision360, Inc. to distribute the LUMINELLE® DTx Hysteroscopy System in the U.S.
Key Takeaways from the Hysteroscopy Devices Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Hysteroscopy Devices market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Hysteroscopy Devices Market.
Various opportunities available for the other competitor in the Hysteroscopy Devices Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Hysteroscopy Devices market growth in the coming future?
Target Audience who can be benefited from the Hysteroscopy Devices Market Report Study
Hysteroscopy Devices providers
Research organizations and consulting companies
Hysteroscopy Devices-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Hysteroscopy Devices
Various End-users who want to know more about the Hysteroscopy Devices Market and latest technological developments in the Hysteroscopy Devices market.
Frequently Asked Questions for the Hysteroscopy Devices Market:
Hysteroscopy is a procedure that allows a healthcare professional to look inside the uterus to diagnose and treat the causes of various gynecological disorders. The medical devices used during the procedure are in general known as hysteroscopy devices and mainly include hysteroscopes, hysteroscopy fluid management systems, hysteroscopy dilators, and others.
The global hysteroscopy devices market was valued at USD 1.29 billion in 2023, growing at a CAGR of 7.40% during the forecast period from 2024 to 2030, to reach USD 2.13 billion by 2030.
The major factors driving the demand for Hysteroscopy Devices are the growing geriatric women population across the globe coupled with growing cases of gynecological disorders. Furthermore, shifting preferences towards minimally invasive surgeries, technological advancements in the product arena, and rising product approvals, among others, are also expected to drive the growth of the global hysteroscopic devices market.
Some of the key market players operating in the Hysteroscopy Devices market include Medtronic, Olympus, Stryker, Hologic, Boston Scientific Corporation, KARL STORZ, Richard Wolf GmbH., Advin Health Care, Ethicon (Johnson & Johnson), MEDGYN PRODUCTS, INC., CooperSurgical Inc., Cook, Maxer Endoscopy GmbH, Meditrina, Inc., XION, EMOS Technology GmbH, LUMINELLE® (UVision360), LiNA Medical ApS, RUDOLF Medical GmbH + Co. KG, Ackermann, among others.
Among all the regions, North America is expected to occupy a major share in the overall Hysteroscopy Devices market during the forecasted period, 2024-2030. This domination is owing to the rapidly increasing concern of gynecological and reproductive health problems among the female in the region. Also, the rise in hysteroscopic procedures in the region, the presence of well-established reimbursement policies for hysteroscopy, and the growing awareness about women's health, among others are expected to bolster the market for hysteroscopic devices.